Dr. William Kelly, MD
Claim this profileThomas Jefferson University
Studies Prostate Cancer
Studies Tumors
7 reported clinical trials
14 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
PALB2 positive
PPP2R2A positive
2Tumors
Affiliated Hospitals
Clinical Trials William Kelly, MD is currently running
Imipramine + Lomustine
for Glioblastoma
This trial is testing both surgical and non-surgical treatments to see how well they work for patients who need these types of interventions.
Recruiting1 award Phase 210 criteria
Radium-223 + M3814 + Avelumab
for Prostate Cancer
This phase I/II trial studies the best dose of M3814 when given together with radium-223 dichloride or with radium-223 dichloride and avelumab and to see how well they work in treating patients with castrate-resistant prostate cancer that had spread to other places in the body (metastatic). M3814 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radioactive drugs, such as radium-223 dichloride, may carry radiation directly to tumor cells and not harm normal cells. Immunotherapy with monoclonal antibodies, such as avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This study is being done to find out the better treatment between radium-223 dichloride alone, radium-223 dichloride in combination with M3814, or radium-223 dichloride in combination with both M3814 and avelumab, to lower the chance of prostate cancer growing or spreading in the bone, and if this approach is better or worse than the usual approach for advanced prostate cancer not responsive to hormonal therapy.
Recruiting1 award Phase 1 & 2
More about William Kelly, MD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments William Kelly, MD has experience with
- ELU001
- Olaparib
- Radium-223 Dichloride
- M3814
- Avelumab
- Rucaparib Camsylate
Breakdown of trials William Kelly, MD has run
Prostate Cancer
Ovarian Cancer
Clear Cell Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William Kelly, MD specialize in?
William Kelly, MD focuses on Prostate Cancer and Tumors. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are PALB2 positive.
Is William Kelly, MD currently recruiting for clinical trials?
Yes, William Kelly, MD is currently recruiting for 5 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that William Kelly, MD has studied deeply?
Yes, William Kelly, MD has studied treatments such as ELU001, Olaparib, Radium-223 Dichloride.
What is the best way to schedule an appointment with William Kelly, MD?
Apply for one of the trials that William Kelly, MD is conducting.
What is the office address of William Kelly, MD?
The office of William Kelly, MD is located at: Thomas Jefferson University, Philadelphia, Pennsylvania 19107 United States. This is the address for their practice at the Thomas Jefferson University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.